Acute Pain. Acute pain
Conditions
Interventions
Intervention 1: Group A or Group piroxicam in the first session dialysis procedure and without any interference cannulation performed at the second session an hour before cannulation of 2 g of piroxic
Treatment - Drugs
Placebo
Group B or Group ointment Spelling: In the first session dialysis procedure and without any interference cannulation performed at the second session an hour before cannulation of 2 g of ointment spell
Group A or Group piroxicam in the first session dialysis procedure and without any interference cannulation performed at the second session an hour before cannulation of 2 g of piroxicam in fistula ru
Group C or placebo in the first session dialysis procedure and without any interference cannulation performed at the second session an hour before cannulation of 2 g of ointment A + D in fistula rubbe
Sponsors
Lorestan University of Medical Sciences, Research
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. The patient is willing to cooperate and participate in the research. 2. The patient has given informed consent to participate in research. 3. Age is between 18-80 years old. 4. Starting hemodialysis at lease 3 months before. 5. Patients don’t have verbal disability, mental and vision problems. 6. Patients don’t have prior history of mental illness or psychiatric hospitalization. 7. The patient is not addict. 8. The patient has no pain medication dependency. 9. The patient has no pain before cannulation. 10. The patient has not used sedative drugs in the last 24 hours of cannulation . 11. The fistula skin is not injured. 12. Patients don’t have history of G6PD, congenital or idiopathic Methemoglobinemia, liver disease, asthma, skin allergies, dermatitis, rash, thrombophlebitis, gastrointestinal bleeding. 13. Patients don’t have sensitivity to local anesthetic drugs, nonsteroidal anti-inflammatory drugs and other medicines. 14. Patients not be treated with sulfonamide drugs, nitrates and phenobarbital. Exclusion criteria: 1. Patient does not wish to continue research. 2. The patient is referred to another center. 3. If unsuccessful on the first attempt and repeated cannulation needle into the skin.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The pain of fistula cannulation. Timepoint: firstly without interference - the second after intervention. Method of measurement: visual pain scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Short-term effects of topical drugs (piroxicam, EMLA cream and ointment A + D). Timepoint: one hour after the drug. Method of measurement: observed effects. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Mohseni
Lorestan University of Medical Sciences
Outcome results
None listed